Skip to content

Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive Function

Transcranial Low Intensity Focused Ultrasound Neuromodulation as a Probe to Study Human Emotion and Cognitive Function

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05194332
Enrollment
0
Registered
2022-01-18
Start date
2026-01-01
Completion date
2028-01-01
Last updated
2026-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder, Major

Keywords

depression, mental illness

Brief summary

The purpose of this study is to assess the low-intensity focused ultrasound pulsation (LIFUP) neuromodulation on emotion processing in healthy individuals, and to assess the overall safety of the LIFUP to stimulate or inhibit brain activity in healthy volunteers.

Interventions

DEVICELIFUP sonication to the amygdala

LIFUP sonication to amygdala will be performed.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Must be right-handed * Must be illicit drug-free at the time of scanning as appropriate (verified by negative urine drug screen) * Must be healthy (without medical, neurological, psychiatric illness) * Must be psychotropic medication free (≥ 14 days)

Exclusion criteria

* Must not be a smoker * Females must not be pregnant or nursing * Must not suffer from claustrophobia * Must not meet

Design outcomes

Primary

MeasureTime frame
Changes in amygdala activity indicated by functional magnetic resonance imaging (fMRI) scan blood oxygen-level-dependent (BOLD) signalbaseline, 5 mins post-LIFUP sonication
Changes in brain resting state functional network as indicated by fMRI scan connectivity measuresbaseline, 10-20 mins post-LIFUP sonication

Secondary

MeasureTime frame
Change in performance on Reward Taskbaseline, 1-hour post-LIFUP sonication
Tolerability of LIFUP sonication as assessed number of adverse eventsbaseline, immediately after LIFUP sonication

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJair Soares, MD, PhD

The University of Texas Health Science Center, Houston

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026